Predictors of vision impairment in Multiple Sclerosis
暂无分享,去创建一个
Sara Llufriu | Pablo Villoslada | Magi Andorra | Yolanda Blanco | Irene Pulido-Valdeolivas | Irati Zubizarreta | I. Zubizarreta | I. Pulido-Valdeolivas | P. Villoslada | M. Andorrà | N. Solà-Valls | M. Sepúlveda | Y. Blanco | A. Saiz | S. Llufriu | B. Sánchez-Dalmau | Albert Saiz | Nuria Sola-Valls | Maria Sepulveda | Elena H Martinez-Lapiscina | Bernardo Sanchez-Dalmau | Ana Guerrero | Salut Alba | Anna Camos | Laura Sanchez-Vela | Veronica Alfonso | Verónica Alfonso | L. Sánchez-Vela | E. Martinez-Lapiscina | A. Guerrero | Salut Alba | A. Camos | Irati Zubizarreta | Magí Andorrà | Núria Solà-Valls
[1] D. Pélisson,et al. Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability , 2013, Multiple sclerosis.
[2] M. Maguire,et al. New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis , 2000, Multiple sclerosis.
[3] Sara Llufriu,et al. Trans‐synaptic axonal degeneration in the visual pathway in multiple sclerosis , 2014, Annals of neurology.
[4] F. Paul,et al. Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis , 2014, BMC Neurology.
[5] R. Marrie,et al. “Seeing” in NARCOMS: a look at vision-related quality of life in the NARCOMS registry , 2013, Multiple sclerosis.
[6] O Garcea,et al. Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test , 2006, Multiple sclerosis.
[7] I. Zubizarreta,et al. The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS , 2014, BMC Research Notes.
[8] P. Villoslada,et al. Color vision is strongly associated with retinal thinning in multiple sclerosis , 2012, Multiple sclerosis.
[9] K. Trinkaus,et al. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis. , 2016, Multiple sclerosis and related disorders.
[10] Hiroshi Ishikawa,et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. , 2012, Ophthalmology.
[11] S. Reingold,et al. The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.
[12] B. Uitdehaag,et al. Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis , 2017, Multiple sclerosis.
[13] Alexander Klistorner,et al. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study , 2016, The Lancet Neurology.
[14] M. Maguire,et al. Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. , 2002, American journal of ophthalmology.
[15] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[16] M. Maguire,et al. Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. , 2006, American journal of ophthalmology.
[17] Christian Confavreux,et al. Recommendations from the national multiple sclerosis society clinical outcomes assessment task force , 1997, Annals of neurology.
[18] I. Zubizarreta,et al. Early retinal atrophy predicts long-term visual impairment after acute optic neuritis , 2017, Multiple sclerosis.
[19] Pablo Villoslada,et al. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies , 2016, Neurology.
[20] Carol Lakkis,et al. The new Richmond HRR pseudoisochromatic test for colour vision is better than the Ishihara test , 2006, Clinical & experimental optometry.
[21] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[22] W. Omulecki,et al. Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.
[23] Fiona Costello,et al. Vision Disturbances in Multiple Sclerosis , 2016, Seminars in Neurology.
[24] Axel Petzold,et al. The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment , 2012, PloS one.
[25] P. Villoslada,et al. Color vision impairment in multiple sclerosis points to retinal ganglion cell damage , 2015, Journal of Neurology.
[26] David H. Miller,et al. Vision and vision-related outcome measures in multiple sclerosis , 2014, Brain : a journal of neurology.
[27] S. Gold,et al. Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable , 2008, Multiple sclerosis.
[28] Lynn D. Hudson,et al. Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis , 2017, Multiple sclerosis.
[29] Sara Llufriu,et al. Colour vision impairment is associated with disease severity in multiple sclerosis , 2014, Multiple sclerosis.